Skip to content

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

← back to feed
Revenue (TTM)
$0
−52.5% YoY Q3 Nov 2019
Net Income (TTM)
−$73.85M
−4.5% YoY Q3 Nov 2019
EPS Diluted (TTM)
—
Q3 Nov 2019
Gross Margin
—
Q3 Nov 2019
Operating Margin
—
Q3 Nov 2019
Net Margin
—
Q3 Nov 2019
Free Cash Flow (TTM)
−$67.18M
Q3 Nov 2019
Cash
$43.57M
Q3 Nov 2019
Total Debt
$131K
Q3 Nov 2019
Shares Outstanding
140.05M sh
Q3 Nov 2019

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings